About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved
Gravis Robotics is a high-growth Series A start-up backed by SoftBank, bringing Physical AI to the construction industry, turning heavy construction machines into autonomous robots. Gravis began as an ETH Zurich spin-out, and our unique combination
Eawag, the Swiss Federal Institute of Aquatic Science and Technology, is an internationally networked aquatic research institute within the ETH Domain (Swiss Federal Institutes of Technology). Eawag conducts research, education and expert consulting to achieve the dual